Industry News
-
Use of CPAP for sleep apnea reduces blood pressure for patients with difficult to treat hypertension
Among patients with obstructive sleep apnea and hypertension that requires 3 or more medications to control, continuous positive airway pressure (CPAP) treatment for 12 weeks resulted in a decrease in 24-hour average and diastolic blood pressure... -
Increased risk of serious sleep breathing disorder in quadriplegics
There are over a million people with spinal cord injuries (SCI) in the United States alone with an estimated 11,000 new cases every year. Furthermore, it is estimated that there are, at least, 100,000 veterans with SCI, making the VA the largest...
DeVilbiss News
DeVilbiss Healthcare’s PulmoNeb® LT System Now Made in the USA*
SOMERSET, PA – November 15, 2013 – DeVilbiss Healthcare re-introduced today the PulmoNeb LT Compressor Nebulizer System, now made in the USA of US and imported parts.
CPAP Auto-Titration Research Study
If you meet certain requirements, you could take part in a research study focused on improving the accuracy of CPAP treatment and better meeting each person’s individualized treatment requirements automatically.
To qualify, you must:
- Have a diagnosis of moderate to severe obstructive sleep apnea, or central/complex sleep apnea
- Be on stable CPAP or APAP therapy with compliant use averaging four or more hours nightly, for at least the past three months
- Be 21 to 75 years or age
Participation Overview
This study includes two visits to the NeuroCare Center for Sleep in Newton, MA, a suburb of Boston:
- Visit 1: screening.
- Visit 2: overnight PSG in sleep lab.
Compensation
- $50 for screening; $200 participation. Total $250 to qualified participants
If interested, please complete the information to the right and “submit.” We will then contact you.
Receive E-Mail Updates
